RSS-Feed abonnieren
DOI: 10.1055/s-0029-1219566
Synthesis of Symmetrical Ureas by (Diacetoxyiodo)benzene-Induced Hofmann Rearrangement
Publikationsverlauf
Publikationsdatum:
02. März 2010 (online)

Abstract
Amides undergo Hofmann rearrangement by treatment with (diacetoxyiodo)benzene (DAIB) to provide symmetrical ureas in a simple and robust transformation.
Key words
Hofmann rearrangement - ureas - carbamates - diacetoxyiodobenzene
- 1a
Vachal P.Jacobsen EN. J. Am. Chem. Soc. 2002, 124: 10012 - 1b
Yang D.Chen Y.-C.Zhu N.-Y. Org. Lett. 2004, 6: 1577 - 1c
Taylor MS.Jacobsen EN. J. Am. Chem. Soc. 2004, 126: 10558 - 1d
Yoon TP.Jacobsen EN. Angew. Chem. Int. Ed. 2005, 44: 466 - 1e
Fuerst DE.Jacobsen EN. J. Am. Chem. Soc. 2005, 127: 8964 - 1f
McCooey SH.Connon SJ. Angew. Chem. Int. Ed. 2005, 44: 6367 - 1g
Taylor MS.Tokunaga N.Jacobsen EN. Angew. Chem. Int. Ed. 2005, 44: 6700 - 1h
Xu X.Furukawa T.Okino T.Miyabe H.Takemoto Y. Chem. Eur. J. 2006, 12: 466 - 1i
Lalonde MP.Chen Y.Jacobsen EN. Angew. Chem. Int. Ed. 2006, 45: 6366 - 1j
Han C.Porco JA. Org. Lett. 2007, 9: 1517 - 1k
Tan KL.Jacobsen EN. Angew. Chem. Int. Ed. 2007, 46: 1315 - 1l
Procuranti B.Connon SJ. Chem. Commun. 2007, 1421 - 1m
Shi Y.-L.Shi M. Adv. Synth. Catal. 2007, 349: 2129 - 1n
Rampalakos C.Wulff WD. Adv. Synth. Catal. 2008, 350: 1785 - 1o
Yalalov DA.Tsogoeva SB.Shubina TE.Martynova IM.Clark T. Angew. Chem. Int. Ed. 2008, 47: 6624 - 1p
Fang Y.-Q.Jacobsen EN. J. Am. Chem. Soc. 2008, 130: 5660 - 1q
Andrés JM.Manzano R.Pedrosa R. Chem. Eur. J. 2008, 14: 5116 - 1r
Reisman SE.Doyle AG.Jacobsen EN. J. Am. Chem. Soc. 2008, 130: 7198 - 1s
Alemán J.Milelli A.Cabrera S.Reyes E.Jørgensen KA. Chem. Eur. J. 2008, 14: 10958 - 1t
Kotecki BJ.Fernando DP.Haight AR.Lukin KA. Org. Lett. 2009, 11: 947 - 1u
Wang F.Liu X.Cui X.Xiong Y.Zhou X.Feng X. Chem. Eur. J. 2009, 15: 589 - 1v
Reis Ö.Eymur S.Reis B.Demir AS. Chem. Commun. 2009, 1088 - For reviews, see:
- 2a
Taylor MS.Jacobsen EN. Angew. Chem. Int. Ed. 2006, 45: 1520 - 2b
Connon SJ. Chem. Commun. 2008, 2499 - 2c
Zhang Z.Schreiner PR. Chem. Soc. Rev. 2009, 38: 1187 - 3a
Batt DG.Houghton GC.Roderick J.Santella JB.Wacker DA.Welch PK.Orlovsky YI.Wadman EA.Trzaskos JM.Davies P.Decicco CP.Carter PH. Bioorg. Med. Chem. Lett. 2004, 15: 787 - 3b
Vidaluc J.-L, andBigg D. inventors; USPTO 5288758. - 3c
Rautenberg W,Harting J,Greiner H,Bartoszyk G,Böttcher H,Van Amsterdam C, andMatzen L. inventors; EP 1140898. - 3d
Kaplan AP, andGupta V. inventors; USPTO 20080306048. - 4a
Bankston D.Dumas J.Natero R.Riedl B.Monahan M.-K.Sibley R. Org. Process Res. Dev. 2002, 6: 777 - 4b
Clark JW.Eder JP.Ryan D.Lathia C.Lenz H.-J. Clin. Cancer Res. 2005, 11: 5472 - 4c
Wilhelm S.Carter C.Lynch M.Lowinger T.Dumas J.Smith RA.Schwartz B.Simantov R.Kelley S. Nat. Rev. Drug Discovery 2006, 5: 835 - 4d
Murphy DA.Makonnen S.Lassoued W.Feldman MD.Carter C.Lee WMF. Am. J. Pathol. 2006, 169: 1875 - 4e
Steinbild S.Mross K.Frost A.Morant R.Gillessen S.Dittrich C.Strumberg D.Hochhaus A.Hanauske A.-R.Edler L.Burkholder I.Scheulen M. Br. J. Cancer 2007, 97: 1480 - 5a
Fabian MA.Biggs WH.Treiber DK.Atteridge CE.Azimioara MD.Benedetti MG.Carter TA.Ciceri P.Edeen PT.Floyd M.Ford JM.Galvin M.Gerlach JL.Grotzfeld RM.Herrgard S.Insko DE.Insko MA.Lai AG.Lélias J.-M.Mehta SA.Milanov ZV.Velasco AM.Wodicka LM.Patel HK.Zarrinkar PP.Lockhart DJ. Nat. Biotechnol. 2005, 23: 329 - 5b
Quesada AR.Munoz-Chápuli R.Medina MA. Med. Res. Rev. 2006, 26: 483 - 5c
Liao JJ.-L. J. Med. Chem. 2007, 50: 409 - 6a
Jackson RC.Weber G. Nature 1975, 256: 331 - 6b
Markland W.McQuaid TJ.Jain J.Kwong AD. Antimicrob. Agents Chemother. 2000, 44: 859 - 6c
Gu HH.Iwanowicz EJ.Guo J.Watterson SH.Shen Z.Pitts WJ.Dhar TGM.Fleener CA.Rouleau K.Sherbina NZ.Witmer M.Tredup J.Hollenbaugh D. Bioorg. Med. Chem. Lett. 2002, 12: 1323 - 7a
Rudzevich Y.Cao Y.Rudzevich V.Böhmer V. Chem. Eur. J. 2008, 14: 3346 - 7b
Chauhan SMS.Bisht T.Garg B. Tetrahedron Lett. 2008, 49: 6646 - 7c
dos Santos CMG.McCabe T.Watson GW.Kruger PE.Gunnlaugsson T. J. Org. Chem. 2008, 73: 9235 - 7d
Ye S.Ding Q.Wang Z.Zhou H.Wu J. Org. Biomol. Chem. 2008, 6: 4406 - 7e
Cui Y.-M.Yasutomi E.Otani Y.Yoshinaga T.Ido K.Sawada K.Ohwada T. Bioorg. Med. Chem. Lett. 2008, 18: 5201 - 7f
Clayden J.Lemiègre L.Morris GA.Pickworth M.Snape PJ.Jones LH. J. Am. Chem. Soc. 2008, 130: 15193 - Reviews:
- 8a
Stang PJ.Zhdankin VV. Chem. Rev. 2008, 108: 5299 - 8b
Zhdankin VV. ARKIVOC 2009, (i): 1 - 9a
Loudon GM.Radhakrishna AS.Almond MR.Blodgett JK.Boutin RH. J. Org. Chem. 1984, 49: 4272 - 9b
Lazbin IM.Koser GF. J. Org. Chem. 1986, 51: 2669 - 9c
Vasudevan A.Koser GF. J. Org. Chem. 1988, 53: 5158 - 11 See also:
Moriarty RM.Chany CJ.Vaid RK.Prakash O.Tuladhar SM. J. Org. Chem. 1993, 58: 2478 - 12
Irschik H.Gerth K.Höfle G.Kohl W.Reichenbach H. J. Antibiot. 1983, 36: 1651 - 13
Irschik H.Jansen R.Höfle G.Gerth K.Reichenbach H. J. Antibiot. 1985, 38: 145
References and Notes
Representative Procedure (Table 1, Entry 1): A solution of benzamide (121 mg, 1.00 mmol), PhI(OAc)2 (DAIB; 419 mg, 1.30 mmol) and H2O (54 µL, 3.00 mmol) in CH2Cl2 (10 mL) was stirred at ambient temperature for 16 h. The resulting solution was stirred at 40 ˚C for 1 h, then the solution was concentrated under vacuum and the remaining residue was purified by column chromatography on silica gel (hexane-EtOAc, 3:1) to yield the corresponding urea as a colorless solid (52.4 mg, 49%).